"OBJ were going to licence it but deal wasnt completed for some...

"OBJ were going to licence it but deal wasnt completed for some unknown reason".

I'm glad you touched on that Malmanu if you read all the OBJ announcements around that time you'll see OBJ was in a tight cash situation as well as the GFC rolled along. There was even a GM held to kick out most of the existing directors just after they showed interest in Breathe Assist in late 2008. The Directors survived at the time but went on a severe cost cutting program to stay afloat, which I think they have managed to do. OBJ's 2009 AR will outline the measures they took.

In this 2009 announcement you'll see they had concerns whether they could committ to get Breathe Assist market ready.

http://www.asx.com.au/asxpdf/20090210/pdf/31fzl0fz77d8vn.pdf

To their credit both Rod Tomlinson & Paz Maryanka persisted after the OBJ deal fell through before finding a home in HCG which later became CGP.

I believe Tomlinson & Maryanka still have large CGP shareholdings today. (Last time I checked the register at Easter they were still there). Indeed until September last year Tomlinson was chairman of CGP.

For me the time duration shows how hard and brutal it has been for many small bios to stay afloat let alone get up and running successfully post GFC.

I think CGP underestimated what was required in 2011-12 and maybe got distracted by having four products in their stable and lost some focus as they bit of more than they could chew.

Things were still looking ok until about this time last year but the DD on a $30m licencing deal dragged on and ultimately fell through.

It took me awhile to reconcile and accept what was unraveling last year but I'm quite comfortable with were we are now and grateful for another chance. I've met with all the new management team and now make a point of staying in touch.

For now I like the new energy and focus MR and MJ have bought to CGP and I also like the investors that have faith in MR based on past experiences.

Make no mistake, this is long overdue so cgp now needs to hit some of the short term targets that they outlined to maintain shareholder faith. They know that.

From the last GM it was stated that BA needed to achieve 3 things:
1. Had to work with regards to airflow (ie. the 38% increase)
2. Had to be comfortable to wear. I also think this includes people being comfortable with the concept of putting something up their nose.
3. It had to stay in for the intended purpose and duration.

They always believed #1 was covered. As for #2 I think the new team wanted their own trials and surveys conducted and that is what took place recently. Prior to the last trial some feedback (not all) was that it may have been a bit hard. I'm sure they have worked on this. As for #3 I think recent trials have also helped refine the product.

At the GM they were also very clear that the product would most likely evolve over time and even for say the BOLT product that there may be different versions released over time.

Like asf said none of us expect this to be BHP, but with the right team it may do quite well in due course.